Hope Medicine completed US$56 million in Series B financing, strengthening capabilities of global innovation
May 6, 2021 — 08:00 CST
This Data Is Locked!
This area is available only to Subscribers.
SHANGHAI, May 6, 2021 /PRNewswire/ -- Recently, the global innovative drug R&D company Hope Medicine Inc. (referred to as "HopeMed") announced the completion of a Series... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
